High-dose cisplatin in hypertonic saline: Reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California oncology group pilot study in non-small-cell lung cancer

David R Gandara, M. W. DeGregorio, H. Wold, B. J. Wilbur, M. Kohler, H. J. Lawrence, A. B. Deisseroth, C. B. George

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose cisplatin in hypertonic saline: Reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California oncology group pilot study in non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences